2-Chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 250mg

4-Bromo-2-methoxy-1-(trifluoromethyl)benzene, 95.0%, 10g

2-(2-((2-Ethylphenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

Gilteritinib, 95%, 250mg

4-(3-(4-HYDROXYPHENYL)-4,4-DIMETHYL-5-OXO-2-THIOXOIMIDAZOLIDIN-1-YL)-2-(TRIFLUOROMETHYL)BENZONITRILE, 95%, 5g

(S)-2-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)acetic acid, 95%, 5g

3,5-Di(2-pyridyl)pyrazole>98.0%(GC)(T)5g

Methyl 6-oxo-1,6-dihydropyridazine-4-carboxylate, 95.0%, 1g

2-Butyl-n-octan-1-amine, >98.0%(T), 25g

4,4'-(Benzo[c][1,2,5]thiadiazole-4,7-diyl)dianiline, 98%, 100mg

4-Methoxyphenylacetone>97.0%(GC)100mL

1-Isocyanato-2-methylsulfanylethane, 250mg

N-(4-Acetylphenyl)-3-chloropropanamide, 98.0%, 10g